Combine bilateral submandibular and sublingual swelling, macroglossus, and carpal tunnel syndrome caused by light chain amyloidosis

Ear, Nose and Throat Journal

Volumn 77, Issue 2, 1998, Pages 95-101

  Jønsson, Viggo ^a,b   Rasmussen, Niels ^a,b   Juhl, Birgitte Ravn ^a,b   Gimsing, Peter ^a,b   Vorstrup, Sissel ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BENCE JONES PROTEIN; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LIGHT CHAIN;

ADULT; AGED; AMYLOIDOSIS; ARTICLE; BIOPSY; CARPAL TUNNEL SYNDROME; CASE REPORT; FEMALE; HUMAN; HUMAN TISSUE; MACROGLOSSIA; MALE; MULTIPLE MYELOMA; PROTEINURIA; SALIVARY GLAND DISEASE; SUBLINGUAL GLAND; SUBMANDIBULAR GLAND; EDEMA; FATALITY; JAW DISEASE; MIDDLE AGED; PREDICTION AND FORECASTING; TONGUE DISEASE;

AGED; AGED, 80 AND OVER; AMYLOIDOSIS; BIOPSY; CARPAL TUNNEL SYNDROME; EDEMA; FATAL OUTCOME; FEMALE; HUMANS; IMMUNOGLOBULIN LIGHT CHAINS; MALE; MANDIBULAR DISEASES; MIDDLE AGED; MULTIPLE MYELOMA; PREDICTIVE VALUE OF TESTS; TONGUE DISEASES;

EID: 0031992850     PISSN: 01455613     EISSN: None     Source Type: Journal    
DOI: 10.1177/014556139807700207     Document Type: Article

References (14)

1. Foerster J. Amyloidosis. In: Lee GR, Bithell TC, Foerster J, et al (eds): Wintrobe's Clinical Hematology. Philadelphia, Lea and Febiger 1993; 2271-83.
2. Hawkins PN. Amyloidosis. Blood Rev 1995; 9:135-42.
3. Hawkins PN, Lavender JP, Pepys MB. Evaluation of systemic amyloidosis by scintigraphy with 123I-labeled serum amyloid P component. N Engl J Med 1990; 323: 508-13.
4. Hutchinson WL, Mather SJ, Staltieri M, et al. Scintigraphic imaging of amyloid deposits with 99mTc-labelled serum amyloid P component. In: Kisilevsky R, Benson MD, Frangione B, Gauldie J, Muckle TJ, Young ID (eds). Amyloid and Amyloidosis 1993. Pearl River, New York: Parthenon Publishing, 1994: 682-4.
5. Kyle RA, Greipp RR. Amyloidosis (AL): Clinical and laboratory features in 229 cases. Mayo Clin Proc 1983; 59: 665-83.
6. Gertz MA, Kyle RA, Greipp PR. Response rates and survival in primary systemic amyloidosis. Blood 1991; 77: 257-62.
7. Brown MP, Walls RS. Amyloidosis of immunoglobin origin: Useful treatment. Med J Aust 1990; 152: 95-100.
8. Solomon A, Weiss DT. Ominous consequences of immunoglobulin deposition. N Engl J Med 1993; 329: 1422-3.
9. van Buren M, Hené RS, Verdonck LF, Verzigbergen FJ, Lokhorst H. Clinical remission after syngenic bone marrow transplantation in a patient with AL amyloidosis. Ann Intern Med 1995; 122: 508-10.
10. Mariette X, Clauvel JP, Brouet JC. Intensive therapy in AL amyloidosis and light-chain deposition disease. Ann Intern Med 1995; 123: 553.
11. Scheinberg MA, Cathcat ES. Comprehensive study of humoral and cellular immune abnormalities in 26 patients with systemic amyloidosis. Arthritis Rheum 1976; 19: 173-8.
12. Wolf BC, Kumar A, Vera JC, Neiman RS. Bone marrow morphology and immunology in systemic amyloidosis. Am J Clin Pathol 1986; 86: 84-8.
13. Durie BGM, Salmon SE. A clinical staging system for multiple myeloma. Cancer 1975; 36: 842-54.
14. Greipp PR, Lust JA, O'Fallon WM, et al. Plasma cell labelling index and ß-2 microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myeloma. Blood 1993; 81: 3382-7.